Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Clume Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Clume Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 62 · Grade C

Clume Health

Visit Clume Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 78 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Clume Health a bad call — it's best for readers who want ongoing clinical support and education and will obtain a medication-specific quote before subscribing. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
83
Transparency
90
94
Access Breadth
93
96
Clinical Oversight
92
77
Track Record
88
79
CoreAge RxBrief Score 94 · 78Clume Health

Price, coverage & the tracker

CoreAge RxClume Health
Brief Score94/100 (A)78/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current price

Earlier listing: From $259/mo (compounded) (checked September 2026).

Confirm the medication, billing term and full charge before paying.

Full price details

Compounded semaglutide offered. Current medication quote unknown; earlier listing: From $259/mo (compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm current price

Earlier listing: From $259/mo (compounded) (checked September 2026).

Confirm the medication, billing term and full charge before paying.

Full price details

Compounded tirzepatide offered. Current medication quote unknown; earlier listing: From $259/mo (compounded)

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states and DC claimed, no list published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Clume Health: Earlier medication prices remain historical. The current $199 starting offer spans standard GLP-1 and microdose programs; confirm the selected medication, included services and renewal charge.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.